All stock lists
Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
$10.64+$0.02 (+0.19%)
Market cap
$898M
Insider Score
Health Score
Analyst consensus
Listed since
Mar 23, 2016
Website
Insider Score
82/ 100
CRVS Insider Score
Bullish4 qualifying trades · 1 insider · $50.48K bought in the last 90 days
Corporate Lobbying
Government lobbying spending instances
Loading filings…
Source: U.S. Senate LDA
Corporate Lobbying
CRVS Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New CRVS patent grants
Loading patent grants…
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to CRVS from public contracts
Source: USAspending.gov
Recently reported changes in CRVS holdings by institutional investors
Scanning latest 13F filings…
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Congressional Trades
U.S. House and Senate disclosures referencing CRVS, reported under the STOCK Act.
| No congressional trades recorded for CRVS. | ||||
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.